T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODV
1926
DELISTED
ModivCare
MODV
| $738K | ﹤0.01% |
23,416
-79,776
| -77% | -$3.12M |
|
1927
First Busey Corp
BUSE
$2.58B
| $737K | ﹤0.01% |
38,313
+1,024
| +3% | +$21.1K |
|
1928
Universal Corp
UVV
$1.12B
| $737K | ﹤0.01% |
15,597
+2,424
| +18% | +$117K |
|
|
VSXY
1929
Victoria's Secret
VSXY
$7.24B
| $737K | ﹤0.01% |
44,154
+931
| +2% | +$17.6K |
|
1930
WIX.com
WIX
$3.35B
| $736K | ﹤0.01% |
8,005
+200
| +3% | +$17.9K |
|
1931
Impinj
PI
$5.46B
| $734K | ﹤0.01% |
13,323
+1,004
| +8% | +$68.1K |
|
1932
DigitalOcean
DOCN
$15.6B
| $730K | ﹤0.01% |
30,344
+1,060
| +4% | +$37.5K |
|
1933
German American Bancorp
GABC
$1.92B
| $729K | ﹤0.01% |
26,882
+2,744
| +11% | +$78.4K |
|
1934
Cannae Holdings
CNNE
$675M
| $727K | ﹤0.01% |
38,960
+1,765
| +5% | +$34.8K |
|
|
HBI
1935
DELISTED
Hanesbrands
HBI
| $727K | ﹤0.01% |
183,570
+17,865
| +11% | +$86.5K |
|
1936
Liberty Live Group Series C
LLYVK
$9.92B
| $724K | ﹤0.01% |
+22,526
| New | +$746K |
|
1937
RxSight
RXST
$292M
| $724K | ﹤0.01% |
25,911
+622
| +2% | +$18.5K |
|
1938
Tandem Diabetes Care
TNDM
$1.61B
| $724K | ﹤0.01% |
34,816
+2,787
| +9% | +$76.5K |
|
1939
Edgewise Therapeutics
EWTX
$4.69B
| $722K | ﹤0.01% |
125,704
+1,024
| +0.8% | +$6.96K |
|
1940
Wabash National
WNC
$509M
| $720K | ﹤0.01% |
34,060
-1,251
| -4% | -$28.8K |
|
1941
Zeta Global
ZETA
$7.44B
| $718K | ﹤0.01% |
85,892
+17,702
| +26% | +$146K |
|
1942
Caleres
CAL
$461M
| $715K | ﹤0.01% |
24,858
+911
| +4% | +$24.2K |
|
|
RWT
1943
Redwood Trust
RWT
$599M
| $715K | ﹤0.01% |
100,209
| – | – |
|
1944
Univest Financial
UVSP
$1.19B
| $715K | ﹤0.01% |
41,121
+8,971
| +28% | +$165K |
|
|
DEA
1945
Easterly Government Properties
DEA
$1.18B
| $714K | ﹤0.01% |
24,971
+1,970
| +9% | +$67.5K |
|
1946
Acushnet Holdings
GOLF
$5.25B
| $710K | ﹤0.01% |
13,374
+818
| +7% | +$46K |
|
1947
Protolabs
PRLB
$2.21B
| $710K | ﹤0.01% |
26,865
+403
| +2% | +$12.2K |
|
1948
StoneCo
STNE
$2.49B
| $709K | ﹤0.01% |
66,393
+7,282
| +12% | +$89.6K |
|
|
ACH
1949
Accendra Health
ACH
$84.6M
| $708K | ﹤0.01% |
43,753
+3,744
| +9% | +$66.4K |
|
|
FSR
1950
DELISTED
Fisker Inc.
FSR
| $706K | ﹤0.01% |
109,869
+9,226
| +9% | +$56.1K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.